Janux Therapeutics (JANX) FCF Margin (2021 - 2026)

Janux Therapeutics (JANX) reported FCF Margin of 337.8% for Q1 2026, down 178.87% on a QoQ basis from 121.13% in Q3 2025.

Janux Therapeutics (JANX) has 6 years of FCF Margin data on file, last reported at 337.8% in Q1 2026.

  • Quarterly FCF Margin changed N/A year-over-year to 337.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 571.56% (down 7102.0% YoY) and the FY2025 annual result came in at 832.78%, down 41558.0% from the prior year.
  • FCF Margin fell to 337.8% in Q1 2026 per JANX's latest filing, from 121.13% in the prior quarter.
  • Across five years, FCF Margin topped out at 115.92% in Q2 2024 and bottomed at 1440.78% in Q2 2023.
  • The 5-year median for FCF Margin is 464.0% (2023), against an average of 587.56%.
  • The widest annual swing landed in 2022, when FCF Margin tumbled 221293 bps; it then jumped 132486 bps in 2024.
  • Tracing JANX's FCF Margin over 5 years: stood at 491.0% in 2022, then climbed by 21 bps to 390.21% in 2023, then dropped by 16 bps to 451.25% in 2024, then surged by 73 bps to 121.13% in 2025, then plunged by 179 bps to 337.8% in 2026.
  • Per Business Quant, the three latest JANX FCF Margin figures stand at 337.8% (Q1 2026), 121.13% (Q3 2025), and 451.25% (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 Janux Therapeutics 914.29 Mn 914.29 Mn - -337.80%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -337.80%
Sep 30, 2025 -121.13%
Sep 30, 2024 -451.25%
Jun 30, 2024 -115.92%
Mar 31, 2024 -1,185.06%
Dec 31, 2023 -390.21%
Sep 30, 2023 -464.00%
Jun 30, 2023 -1,440.78%
Mar 31, 2023 -693.16%
Dec 31, 2022 -491.00%
Sep 30, 2022 -878.87%
Jun 30, 2022 -319.07%
Mar 31, 2022 -750.03%
Dec 31, 2021 -721.16%
Sep 30, 2021 -531.75%
Jun 30, 2021 -1,286.31%
Mar 31, 2021 1,462.89%